Form 4 for ALXO ALX ONCOLOGY HOLDINGS INC
Accepted 2024-01-03 00:00:00 ET · period of report 2023-12-29 · accession 0001209191-24-000379 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-03 | 2023-12-29 | ALXO | Pinto Shelly | SVP, CAO, Fin | S - Sale | $15.04 | -1,631 | 81.3K | -2% | -$24.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-29 | S | D | 1,631 | $15.04 | 81,308 | D | — | — | (F2) Includes 1,226 shares acquired under the Issuer's employee stock purchase plan on December 29, 2023. |